세포치료제 바이오프로세싱 시장은 2020년 111억 9250만 달러에서 2028년 300억 5261만 달러에 달할 것으로 예상된다. 시장은 2021~2028년 연평균 13.5% 성장할 것으로 예상된다.
세포 치료 바이오 프로세싱 시장은 기술, 세포 유형, 최종 사용자 및 지역을 기준으로 분석되었습니다. 지역 기반 시장은 북미, 유럽, 아시아 태평양, 중동 및 아프리카, 중남미로 분류됩니다. 이 보고서는 시장 동향, 기술 발전, 시장 역학 및 선도 기업의 경쟁 환경 분석과 같은 매개변수를 강조하여 세포 치료 바이오프로세싱 시장에 대한 통찰력과 심층 분석을 제공합니다. 또한 모든 주요 지역의 시장 전반에 걸친 COVID-19 대유행 분석도 포함됩니다.
세포 치료 바이오프로세싱 시장의 수익성 있는 지역
시장 통찰력
세포 치료에 대한 승인 증가
세포 치료는 치료에서 긍정적인 결과를 보였습니다 희귀 유전질환을 비롯한 다양한 만성질환에 대한 재생의료 및 맞춤의료 제공 만성 질환 치료의 필요성이 증가함에 따라 연구 개발 활동이 추진되어 세포 치료제 생산 및 제품 승인이 증가했습니다. 세포 치료 바이오프로세싱 시장의 성장에 기여한 세포 치료 승인에 대한 몇 가지 사례가 아래에 나열되어 있습니다.
- 2019년 5월 식품의약국(FDA)은 Novartis AG의 자회사인 AveXis, Inc.에서 제조한 Zolgensma를 승인했습니다. Zolgensa는 2세 미만 어린이의 척수성 근위축증을 치료하기 위해 고안되었으며 정맥에 1회 주입하여 투여합니다.
- 2020년 7월 Gilead Company의 자회사인 Kite Pharma, Inc.는 FDA 승인을 받았습니다. Tecartus에 대한 승인. Tecartus는 성인의 난치성 맨틀 세포 림프종(MCL)을 치료하기 위해 고안된 (CAR) T 세포 치료제입니다. 토우길리어드컴퍼니에 따르면 테카투스는 맨틀세포림프종에 대한 최초 승인(CAR) T세포 치료제로 맨틀세포림프종 치료의 새로운 지평을 열 것으로 기대된다.
- 2021년 2월 주노 Bristol-Myers Squibb Company의 자회사인 Therapeutics, Inc.는 Breyanzi에 대한 승인을 받았습니다. Breyanzi는 성인의 특정 유형의 거대 B세포 림프종을 치료하기 위한 세포 기반 유전자 요법입니다. 치료는 환자가 최소 두 가지 다른 유형의 전신 치료에 반응하지 않은 후에 제공됩니다. 그러나 2019년 Breyanzi는 첫 제출 이후 규제 차질에 직면했습니다. 현재 유럽 의약품청(European Medicines Agency)의 검토 중이며 2020년 7월에 유효성이 검증되었습니다.
따라서 제품 개발이 증가함에 따라 세포 치료제의 증가를 반영하는 다양한 제품 승인이 이루어졌습니다. 따라서 세포 치료제에 대한 승인이 증가함에 따라 세포 치료제 바이오프로세싱이 엄청나게 증가할 것으로 예상되며, 이는 향후 몇 년 동안 시장의 성장을 주도할 가능성이 높습니다.
기술 기반 통찰력
세포 치료제 바이오프로세싱 시장은 기술별로 바이오리액터, 동결건조, 전기방사, 제어흐름 원심분리, 초음파 용해, 게놈 편집 기술, 세포 불멸화 기술, 바이러스 벡터 기술로 구분된다. 바이오리액터 부문은 2020년 시장에서 가장 큰 점유율을 차지한 반면, 게놈 편집 기술 부문은 예측 기간 동안 시장에서 가장 높은 CAGR 14.5%를 기록할 것으로 예상됩니다.
세포 치료 바이오프로세싱 시장, by 기술- 2020년 및 2028년
세포 유형 기반 통찰력
세포 치료 바이오프로세싱 시장은 세포 유형별로 줄기 세포, 면역 세포, 인간 배아 줄기 세포, 만능 줄기 세포로 분류됩니다. 세포, 조혈모세포. 줄기 세포 부문은 2020년에 시장에서 가장 큰 점유율을 차지한 반면, 동일한 부문은 예측 기간 동안 시장에서 가장 높은 CAGR 14.0%를 기록할 것으로 예상됩니다.
최종 사용자 기반 통찰력
p>
세포 치료제 바이오프로세싱 시장은 적응증에 따라 심혈관 질환(CVD), 종양학, 상처 치유, 정형외과 등으로 세분화됩니다. 종양학 부문은 2020년 시장에서 가장 큰 점유율을 차지했으며 정형외과 부문은 예측 기간 동안 시장에서 가장 높은 CAGR 14.3%를 기록할 것으로 예상됩니다.
전략적 통찰력
세포 치료 바이오프로세싱 시장에서 활동하는 기업들은 제품 출시 및 확장과 같은 유기적 전략을 채택하여 전 세계적으로 입지와 제품 포트폴리오를 확장하고 증가하는 수요를 해결하고 있습니다.
기술별
< ul>
세포 유형별
- 줄기 세포
- 면역세포
- 인간배아줄기세포
- 만능줄기세포
- 조혈줄기세포
적응증별< /p>
- 심혈관 질환(CVD)
- 종양
- 상처 치유
- 정형외과
- 기타
최종 사용자별
- 병원 및 진료소
- 진단 센터
- 재생 의학 센터
- 학술 및 연구 기관
지역별
- 북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 프랑스
- 독일
- 이탈리아
- 영국< /li>
- 스페인
- 기타 유럽
- 아시아 태평양(APAC)
- 중국
- 인도
- 대한민국
- 일본
- 호주
- 기타 APAC
- 남아프리카
- 사우디아라비아
- UAE
- 나머지 MEA
- 중남미(SCAM)
- 브라질
- 아르헨티나
- 나머지 SCAM
< /li> - Fresenius Kabi AG
- Asahi Kasei Corporation
- Sartorius AG
- MERCK KGaA
- THERMO FISHER SCIENTIFIC INC.
- Corning Incorporated
- Cytiva
- Lonza
- Repligen
- Catalent Inc
< li>중동 및 아프리카(MEA)
회사 프로필
li>
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Cell therapy bioprocessing is a subfield of bioprocess engineering that bridges cell therapy and bioprocessing (i.e., biopharmaceutical manufacturing). Cell therapy is one of the fastest-growing areas of the life sciences. It entails delivering entire living cells to a patient to treat disease.
Key factors driving the growth of the market are increasing investments for cell and gene therapy manufacturing, and growing approvals for cell therapies are the major factors driving the market growth. However, challenges such as high cost of product, regulatory challenges, and logistics challenges are likely to hinder the growth of the cell therapy bioprocessing market.
The costs of the Cell Therapy Bioprocessing are much higher, and they may cost US$ 50,000–100,000, or more, per cell therapy. The cost may also differ from product to product types.
The List of Companies - Cell Therapy Bioprocessing Market
- Fresenius Kabi AG
- Asahi Kasei Corporation
- Sartorius AG
- MERCK KGaA
- THERMO FISHER SCIENTIFIC INC.
- Corning Incorporated
- Cytiva
- Lonza
- Repligen
- Catalent Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)